← Leaderboards
Luzhe Sun
University Of Texas Hlth Sci Ctr Houston
$18,197,911
Attributed
$19,832,696
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,832,696 · 11
By mechanism
R01$14,103,282 · 8
T32$2,394,497 · 1
U01$1,860,500 · 1
P01$1,474,417 · 1
Top collaborators
- Jean X Jiang5 shared
- Andrew P Hinck4 shared
- Pei Wang1 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsNeoplastic CellTumorMediatingGrowthIn VitroTumorigenesisMolecularMouse ModelReceptorNeoplasm MetastasisSignal TransductionGenesIncidenceDoseMalignant Breast NeoplasmAttenuatedTransforming Growth Factor BetaAngiogenesisAutocrineTumor ProgressionPathway InteractionsTissues
Grant awards (74)
Aging-associated mammary cancer-initiating cells$381,903
U01 · FY2025 · CA · contact PI
Role of STEAP2 protein in hepatocarcinogenesis$416,619
R01 · FY2024 · CA · contact PI
Aging-associated mammary cancer-initiating cells$348,162
U01 · FY2024 · CA · contact PI
Role of STEAP2 protein in hepatocarcinogenesis$429,775
R01 · FY2023 · CA · contact PI
Aging-associated mammary cancer-initiating cells$374,266
U01 · FY2023 · CA · contact PI
Cancer Biology Training Program$234,635
T32 · FY2023 · CA · contact PI
Role of STEAP2 protein in hepatocarcinogenesis$429,775
R01 · FY2022 · CA · contact PI
Aging-associated mammary cancer-initiating cells$374,266
U01 · FY2022 · CA · contact PI
Cancer Biology Training Program$244,256
T32 · FY2022 · CA · contact PI
Role of STEAP2 protein in hepatocarcinogenesis$438,140
R01 · FY2021 · CA · contact PI
Aging-associated mammary cancer-initiating cells$381,903
U01 · FY2021 · CA · contact PI
Role of STEAP2 protein in hepatocarcinogenesis$449,583
R01 · FY2020 · CA · contact PI
Connexin hemichannels in suppression of breast cancer bone metastasis$367,527
R01 · FY2020 · CA
Cancer Biology Training Program$256,590
T32 · FY2020 · CA · contact PI
Aging mammary stem cells and breast cancer prevention$383,570
R01 · FY2019 · CA · contact PI
Connexin hemichannels in suppression of breast cancer bone metastasis$356,501
R01 · FY2019 · CA
Cancer Biology Training Program$248,449
T32 · FY2019 · CA · contact PI
Aging mammary stem cells and breast cancer prevention$395,434
R01 · FY2018 · CA · contact PI
Connexin hemichannels in suppression of breast cancer bone metastasis$367,527
R01 · FY2018 · CA
Cancer Biology Training Program$227,288
T32 · FY2018 · CA · contact PI
Aging mammary stem cells and breast cancer prevention$395,434
R01 · FY2017 · CA · contact PI
Connexin hemichannels in suppression of breast cancer bone metastasis$355,918
R01 · FY2017 · CA
Cancer Biology Training Program$168,972
T32 · FY2017 · CA · contact PI
Cancer Biology Training Program$3,456
T32 · FY2017 · CA · contact PI
Aging mammary stem cells and breast cancer prevention$395,434
R01 · FY2016 · CA · contact PI
Connexin hemichannels in suppression of breast cancer bone metastasis$355,918
R01 · FY2016 · CA
Effect of bisphenol A exposure on mammary stem cell function and transformation$336,375
R01 · FY2016 · ES · contact PI
Inhibition of the tumor-promoting effects of TGF-beta in advanced prostate cancer$310,213
R01 · FY2016 · CA · contact PI
Cancer Biology Training Program$219,512
T32 · FY2016 · CA · contact PI
Aging mammary stem cells and breast cancer prevention$395,434
R01 · FY2015 · CA · contact PI
Effect of bisphenol A exposure on mammary stem cell function and transformation$336,375
R01 · FY2015 · ES · contact PI
Inhibition of the tumor-promoting effects of TGF-beta in advanced prostate cancer$310,213
R01 · FY2015 · CA · contact PI
Cancer Biology Training Program$190,928
T32 · FY2015 · CA · contact PI
Effect of bisphenol A exposure on mammary stem cell function and transformation$333,011
R01 · FY2014 · ES · contact PI
Inhibition of the tumor-promoting effects of TGF-beta in advanced prostate cancer$300,906
R01 · FY2014 · CA
Cancer Biology Training Program$186,686
T32 · FY2014 · CA · contact PI
Effect of bisphenol A exposure on mammary stem cell function and transformation$329,648
R01 · FY2013 · ES · contact PI
Inhibition of the tumor-promoting effects of TGF-beta in advanced prostate cancer$310,213
R01 · FY2013 · CA
Cancer Biology Training Program$204,635
T32 · FY2013 · CA · contact PI
Effect of bisphenol A exposure on mammary stem cell function and transformation$336,188
R01 · FY2012 · ES · contact PI
TGF beta Receptor and Tumor Progression$215,114
R01 · FY2012 · CA · contact PI
Cancer Biology Training Program$209,090
T32 · FY2012 · CA · contact PI
TGF beta Receptor and Tumor Progression$215,114
R01 · FY2011 · CA · contact PI
Targeting transforming growth factor beta for cancer treatment$212,360
R01 · FY2011 · CA · contact PI
TGFBeta Antagonists and Breast Cancer-Induced Bone Metastasis$317,839
P01 · FY2010 · CA · contact PI
TGF beta Receptor and Tumor Progression$221,767
R01 · FY2010 · CA · contact PI
Targeting transforming growth factor beta for cancer treatment$218,928
R01 · FY2010 · CA · contact PI
TGFBeta Antagonists and Breast Cancer-Induced Bone Metastasis$351,136
P01 · FY2009 · CA · contact PI
Targeting transforming growth factor beta for cancer treatment$218,928
R01 · FY2009 · CA · contact PI
TGF beta Receptor and Tumor Progression$160,226
R01 · FY2009 · CA · contact PI
TGFBeta Antagonists and Breast Cancer-Induced Bone Metastasis$307,163
P01 · FY2008 · CA · contact PI
TGF beta Receptor and Tumor Progression$221,020
R01 · FY2008 · CA · contact PI
Targeting transforming growth factor beta for cancer treatment$218,928
R01 · FY2008 · CA · contact PI
TGFBeta Antagonists and Breast Cancer-Induced Bone Metastasis$304,508
P01 · FY2007 · CA · contact PI
Targeting transforming growth factor beta for cancer treatment$218,928
R01 · FY2007 · CA · contact PI
TGF beta Receptor and Tumor Progression$207,652
R01 · FY2007 · CA · contact PI
TGF beta Receptor and Tumor Progression$44,988
R01 · FY2007 · CA · contact PI
TGF beta Receptor and Tumor Progression$213,854
R01 · FY2006 · CA · contact PI
Targeting Transforming Growth Factor Beta for Cancer Tre$210,509
R01 · FY2006 · CA · contact PI
TGFB Antagonists & Breast Cancer-Induced Bone Metastasis$193,771
P01 · FY2006 · CA · contact PI
TGF beta Receptor and Tumor Progression$46,332
R01 · FY2006 · CA · contact PI
TGF beta Receptor and Tumor Progression$219,000
R01 · FY2005 · CA
Targeting Transforming Growth Factor Beta for Cancer Tre$215,575
R01 · FY2005 · CA
TGF beta Receptor and Tumor Progression$46,332
R01 · FY2005 · CA
TGF beta Receptor and Tumor Progression$219,000
R01 · FY2004 · CA
Targeting Transforming Growth Factor Beta for Cancer Tre$215,575
R01 · FY2004 · CA
TGF beta Receptor and Tumor Progression$29,326
R01 · FY2004 · CA
TGF beta Receptor and Tumor Progression$219,000
R01 · FY2003 · CA
Targeting Transforming Growth Factor Beta for Cancer Tre$215,575
R01 · FY2003 · CA
Targeting Transforming Growth Factor Beta for Cancer Tre$255,068
R01 · FY2002 · CA
CONTROL OF DIFFERENTIATION IN COLON CARCINOMA$237,718
R01 · FY2001 · CA
TGF BETA RECEPTOR AND TUMOR PROGRESSION$168,897
R01 · FY2001 · CA
TARGETING TRANSFORM GROWTH FACTOR B FOR CANCER TREATMENT$213,360
R01 · FY2000 · CA
TGF BETA RECEPTOR AND TUMOR PROGRESSION$168,477
R01 · FY2000 · CA